ESC Premium Access

Young Investigators Awards Session Thrombosis

Event: ESC CONGRESS 2016
Topic: Miscellaneous
Session type: Young Investigator Award Abstracts
Date: 28 August 2016
Time: 12:40 - 13:50

Congress Session

4 presentations in this session

PDK1 determines collagen-dependent platelet activation and is critical to development of arterial thrombosis and ischemic stroke in vivo

Speaker: Doctor O. Borst (Tuebingen, DE)
Thumbnail

Stroke and all cause mortality with non-vitamin K antagonist oral anticoagulation versus warfarin in atrial fibrillation: a nationwide study

Speaker: Doctor L. Staerk (Hellerup, DK)
Thumbnail

A novel risk prediction score in atrial fibrillation for a net clinical outcome from the ENGAGE AF-TIMI 48 randomized clinical trial

Speaker: Doctor C. Fanola (Boston, US)
Thumbnail

Clinical impact and course of major bleeding events in patients with venous thromboembolism, treated with factor Xa inhibitors or vitamin K antagonists: an individual patient data analysis

Speaker: Ms M. Brekelmans (Amsterdam, NL)
Thumbnail

4 speakers from this session

Doctor Oliver Borst

Department of Cardiology and Cardiovascular Medicine, University Hospital Tuebingen, Tuebingen (Germany)
0 follower

Doctor Laila Staerk

Gentofte Hospital - Copenhagen University Hospital, Hellerup (Denmark)
0 follower

Doctor Christina Fanola

Brigham and Women's Hospital, Boston (United States of America)
0 follower

Ms Marjolein Brekelmans

, Amsterdam (Netherlands (The))
0 follower

This platform is supported by

logo Novo Nordisk